<div id="readability-page-1">11:29 AM EST, 12/03/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were gaining Wednesday morning, rising 0.47% to 1,640.67 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and petroleum refiner Equinor ( EQNR ) , which rose 3.3% and 2.6%, respectively. They were followed by biotech firm Evaxion (EVAX) and biopharmaceutical companies Grifols ( GRFS ) , which were up 2.5% and 2.1% respectively.From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company NuCana ( NCNA ) , which fell 6% and 3.8% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and software firm Endava ( DAVA ) , which were down 3.7% and 3.3% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Trinity Biotech ( TRIB ) , which dropped 14% and 2% respectively. They were followed by internet advertising firm Criteo (CRTO) and lender Lloyds Banking Group ( LYG ) , which lost 1.4% and 0.7% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AUTL

Akari治療

NCNA

在美國以 ADR 形式交易的歐洲股票在標準普爾歐洲精選 ADR 指數上上漲了 0.47%。主要漲幅股包括 Sequans Communications 和 Equinor，而 Autolus Therapeutics 和 NuCana 則領跌。Akari Therapeutics 和 Trinity Biotech 也出現了顯著下跌。MT Newswires 提醒謹防未經授權的複製

歐洲股票在美國市場以美國存託憑證形式交易，週三交易中表現上漲